G. Aherne, J. English, and V. Marks, The role of immunoassay in the analysis of microcontaminants in water samples, Ecotoxicology and Environmental Safety, vol.9, issue.1, pp.79-83, 1985.
DOI : 10.1016/0147-6513(85)90037-5

F. Baumann and R. Preiss, Cyclophosphamide and related anticancer drugs, Journal of Chromatography B: Biomedical Sciences and Applications, vol.764, issue.1-2, pp.173-192, 2001.
DOI : 10.1016/S0378-4347(01)00279-1

M. Bedner and W. A. Maccrehan, -benzoquinone Imine, Environmental Science & Technology, vol.40, issue.2, pp.516-522, 2006.
DOI : 10.1021/es0509073
URL : https://hal.archives-ouvertes.fr/hal-00277736

J. Besse and J. Garric, Human pharmaceuticals in surface waters, Toxicology Letters, vol.176, issue.2, pp.104-123, 2008.
DOI : 10.1016/j.toxlet.2007.10.012

J. Besse, J. Latour, and J. Garric, Anticancer drugs in surface waters, Environment International, vol.39, issue.1, pp.73-86, 2012.
DOI : 10.1016/j.envint.2011.10.002

K. Cantor, C. Lynch, M. Hildesheim, M. Dosemeci, J. Lubin et al., Drinking Water Source and Chlorination Byproducts I. Risk of Bladder Cancer, Epidemiology, vol.9, issue.1, pp.21-28, 1998.
DOI : 10.1097/00001648-199801000-00007

S. Castiglioni, R. Bagnati, D. Calamari, R. Fanelli, and E. Zuccato, A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters, Journal of Chromatography A, vol.1092, issue.2, pp.206-215, 2005.
DOI : 10.1016/j.chroma.2005.07.012

S. Castiglioni, R. Bagnati, R. Fanelli, F. Pomati, D. Calamari et al., Removal of Pharmaceuticals in Sewage Treatment Plants in Italy, Environmental Science & Technology, vol.40, issue.1, pp.357-363, 2006.
DOI : 10.1021/es050991m

C. Catastini, J. Mullot, S. Boukari, P. Mazellier, Y. Levi et al., Assessment of antineoplastic drugs in effluents of two hospitals, J. Eur. Hydrol, vol.39, pp.171-180, 2008.

D. Jongh, C. M. Kooij, P. J. De-voogt, P. Ter-laak, and T. L. , Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water, Science of The Total Environment, vol.427, issue.428, pp.70-77, 2012.
DOI : 10.1016/j.scitotenv.2012.04.010

I. Ferrer and E. M. Thurman, Analysis of 100 pharmaceuticals and their degradates in water samples by liquid chromatography/quadrupole time-of-flight mass spectrometry, Journal of Chromatography A, vol.1259, pp.148-157, 1259.
DOI : 10.1016/j.chroma.2012.03.059

J. Gibs, P. E. Stackelberg, E. T. Furlong, M. Meyer, S. D. Zaugg et al., Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time, Science of The Total Environment, vol.373, issue.1, pp.240-249, 2007.
DOI : 10.1016/j.scitotenv.2006.11.003

R. Grabic, J. Fick, R. H. Lindberg, G. Fedorova, and M. Tysklind, Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry, Talanta, vol.100, pp.183-195, 2012.
DOI : 10.1016/j.talanta.2012.08.032

M. Gros, S. Rodríguez-mozaz, and D. Barceló, Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-highperformance liquid chromatography coupled to quadrupolelinear ion trap tandem, J. Chromatogr. A, pp.104-121, 1248.

N. Hamidin, Q. J. Yu, and D. W. Connell, Human health risk assessment of chlorinated disinfection by-products in drinking water using a probabilistic approach, Water Research, vol.42, issue.13, pp.3263-3274, 2008.
DOI : 10.1016/j.watres.2008.02.029

G. Hey, R. Grabic, A. Ledin, J. La-cour-jansen, and H. R. Andersen, Oxidation of pharmaceuticals by chlorine dioxide in biologically treated wastewater, Chemical Engineering Journal, vol.185, issue.186, pp.236-242, 2012.
DOI : 10.1016/j.cej.2012.01.093

M. M. Huber, S. Korhonen, T. A. Ternes, and U. Von-gunten, Oxidation of pharmaceuticals during water treatment with chlorine dioxide, Water Research, vol.39, issue.15, pp.3607-3617, 2005.
DOI : 10.1016/j.watres.2005.05.040

B. Kasprzyk-hordern, R. M. Dinsdale, and A. J. Guwy, The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK, Water Research, vol.42, issue.13, pp.3498-3518, 2008.
DOI : 10.1016/j.watres.2008.04.026

K. Kü-mmerer and A. Ahmad, Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water, Environmental Science and Pollution Research, vol.355, issue.2, pp.486-496, 2010.
DOI : 10.1007/s11356-009-0195-4

Y. Lee and U. Von-gunten, Oxidative transformation of micropollutants during municipal wastewater treatment: Comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrateVI, and ozone) and non-selective oxidants (hydroxyl radical), Water Research, vol.44, issue.2, pp.555-566, 2010.
DOI : 10.1016/j.watres.2009.11.045

B. Li and T. Zhang, pH significantly affects removal of trace antibiotics in chlorination of municipal wastewater, Water Research, vol.46, issue.11, pp.3703-3713
DOI : 10.1016/j.watres.2012.04.018

Z. Li, H. Fenet, E. Gomez, and S. Chiron, Transformation of the antiepileptic drug oxcarbazepine upon different water disinfection processes, Water Research, vol.45, issue.4, 2011.
DOI : 10.1016/j.watres.2010.11.038

R. Ló-pez-serna, M. Petrovi-c, and D. Barceló, Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain), Science of The Total Environment, vol.440, pp.280-289, 2012.
DOI : 10.1016/j.scitotenv.2012.06.027

G. Lu and H. Juna, Determination of Trace Methotrexate and 7-OH-Methotrexate in Plasma by High-Performance Liquid Chromatog-Raphy with Fluorimetric Detection, Journal of Liquid Chromatography, vol.22, issue.1, pp.155-171, 1995.
DOI : 10.1097/00007691-199111000-00011

H. Mash, Assessing the fate and transformation by-product potential of trenbolone during chlorination, Chemosphere, vol.81, issue.7, pp.946-953, 2010.
DOI : 10.1016/j.chemosphere.2010.07.055

J. R. Meier, R. D. Lingg, and R. J. Bull, Formation of mutagens following chlorination of humic acid A model for mutagen formation during drinking water treatment, Mutation Research/Genetic Toxicology, vol.118, issue.1-2, pp.25-41, 1983.
DOI : 10.1016/0165-1218(83)90113-1

M. Meyer, C. Adams, Y. Wang, and K. Loftin, Removal of antibiotics from surface and distilled water in conventional water treatment processes, J. Environ. Eng, vol.128, pp.253-260, 2002.

S. Mompelat, O. Thomas, L. Bot, and B. , Contamination levels of human pharmaceutical compounds in French surface and drinking water, Journal of Environmental Monitoring, vol.32, issue.10, 2011.
DOI : 10.1039/c1em10335k
URL : https://hal.archives-ouvertes.fr/hal-00878545

V. Osorio, R. Marcé, S. Pé-rez, A. Ginebreda, J. L. Cortina et al., Occurrence and modeling of pharmaceuticals on a sewage-impacted Mediterranean river and their dynamics under different hydrological conditions, Science of The Total Environment, vol.440, pp.3-13, 2012.
DOI : 10.1016/j.scitotenv.2012.08.040

M. Petrovic, D. Barcelò, A. Aukidy, M. Verlicchi, P. Jelic et al., Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. Sci. Total Environ, vol.438, pp.15-25, 2012.

M. F. Pouet, E. Baures, S. Vaillant, and O. Thomas, Hidden Isosbestic Point(s) in Ultraviolet Spectra, Applied Spectroscopy, vol.58, issue.4, pp.486-490, 2004.
DOI : 10.1366/000370204773580365

J. B. Quintana, R. Rodil, P. Ló-pez-mahía, S. Muniategui-lorenzo, and D. Prada-rodríguez, Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology, Water Research, vol.44, issue.1, pp.243-255, 2010.
DOI : 10.1016/j.watres.2009.09.018

N. Ratola, A. Cincinelli, A. Alves, and A. Katsoyiannis, Occurrence of organic microcontaminants in the wastewater treatment process. A mini review, Journal of Hazardous Materials, vol.239, issue.240, 2012.
DOI : 10.1016/j.jhazmat.2012.05.040

P. H. Roberts and K. V. Thomas, The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Science of The Total Environment, vol.356, issue.1-3, pp.143-153, 2006.
DOI : 10.1016/j.scitotenv.2005.04.031

G. Roberts, G. Myatt, W. Johnson, K. Cross, and P. J. Blower, :??? Software for Exploring Large Sets of Screening Data, Journal of Chemical Information and Computer Sciences, vol.40, issue.6, 2000.
DOI : 10.1021/ci0000631

R. Rodil, J. B. Quintana, and R. Cela, Transformation of phenazone-type drugs during chlorination, Water Research, vol.46, issue.7, 2012.
DOI : 10.1016/j.watres.2012.02.018

R. Saiakhov, S. Chakravarti, and G. Klopman, Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs, Molecular Informatics, vol.587, issue.1, 2013.
DOI : 10.1002/minf.201200081

J. Salamoun, M. Smrz, F. Kiss, and A. Salamounová, Column liquid chromatography of methotrexate and its metabolites using a post-column photochemical reactor and fluorescence detection, Journal of Chromatography B: Biomedical Sciences and Applications, vol.419, pp.213-223, 1987.
DOI : 10.1016/0378-4347(87)80279-7

M. Soufan, M. Deborde, and B. Legube, Aqueous chlorination of diclofenac: Kinetic study and transformation products identification, Water Research, vol.46, issue.10, pp.3377-3386, 2012.
DOI : 10.1016/j.watres.2012.03.056
URL : https://hal.archives-ouvertes.fr/hal-00705884

P. E. Stackelberg, E. T. Furlong, M. T. Meyer, S. D. Zaugg, A. K. Henderson et al., Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant, Science of The Total Environment, vol.329, issue.1-3, pp.99-113, 2004.
DOI : 10.1016/j.scitotenv.2004.03.015

J. O. Straub, Combined Environmental Risk Assessment for 5-Fluorouracil and Capecitabine in Europe, Integrated Environmental Assessment and Management, vol.preprint, issue.2009, pp.540-566, 2010.
DOI : 10.1897/IEAM_2009-073.1

M. Uchiyama, T. Matsumoto, T. Matsumoto, S. Jimi, Y. Takamatsu et al., Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction, Biomedical Chromatography, vol.4, issue.1, pp.76-80, 2012.
DOI : 10.1002/bmc.1628

P. Verlicchi, A. Aukidy, M. Zambello, and E. , Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment???A review, Science of The Total Environment, vol.429, pp.123-155, 2012.
DOI : 10.1016/j.scitotenv.2012.04.028

C. Wang, H. Shi, C. D. Adams, S. Gamagedara, I. Stayton et al., Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry, Water Research, vol.45, issue.4, 2011.
DOI : 10.1016/j.watres.2010.11.043

P. Wang, Y. He, and C. Huang, Reactions of tetracycline antibiotics with chlorine dioxide and free chlorine, Water Research, vol.45, issue.4, 2011.
DOI : 10.1016/j.watres.2010.11.039

P. Westerhoff, Y. Yoon, S. Snyder, and E. Wert, Fate of Endocrine-Disruptor, Pharmaceutical, and Personal Care Product Chemicals during Simulated Drinking Water Treatment Processes, Environmental Science & Technology, vol.39, issue.17, pp.6649-6663, 2005.
DOI : 10.1021/es0484799

J. Yin, B. Shao, J. Zhang, and K. Li, A Preliminary Study on the Occurrence of Cytostatic Drugs in Hospital Effluents in Beijing, China, Bulletin of Environmental Contamination and Toxicology, vol.58, issue.1, pp.39-45, 2010.
DOI : 10.1007/s00128-009-9884-4

R. Zounková, P. Odrá-ska, L. Dolezalová, K. Hilscherová, B. Marsá-lek et al., Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals, Environ. Toxicol. Chem, vol.26, 2007.